The trial aims to evaluate 12-month long-term efficiency of Excel stent in the treatment of coronary heart disease and inhibition of restenosis after coronary artery stenting as well as a 12 months' long-term safety after the cessation of clopidogrel as an anti-platelet drugs used for 6 months after the implantation of degradable drug coating stent.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
2,077
MACE(Major adverse cardiac events)
Time frame: 12 months
MACE
Time frame: 30 days and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.